DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo

XenoPort, Inc.

NASDAQ: XNPT



company name or ticker

XenoPort Announces New Employment Inducement Awards

XenoPort to Release Second Quarter Financial Results on August 6

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatmen

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatmen

XenoPort Announces Inclusion of Horizant (Gabapentin Enacarbil) in Guidelines for Long-Term Treatment of Restless Legs Syndrome/Willis-Ekbom Disease

Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline

3 Biotech Stocks Under $10 Spiking Higher

XenoPort Announces New Employment Inducement Awards

August 17th Options Now Available For XenoPort (XNPT)

Does Restless Legs Syndrome Really Shorten Life Span?

A new study suggests a link between this neurological disorder and mortality rates in men.

Mid-Day Update: Benzinga's Top Downgrades

See More Articles...